XML 27 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation
6 Months Ended
Dec. 31, 2018
Stock-Based Compensation [Abstract]  
Stock-Based Compensation

5.

STOCK-BASED COMPENSATION



The Company has two stock-based compensation methods available when determining employee compensation.



(1)Long-Term Incentive Compensation Plans



Long-Term Incentive Compensation Plan



The Long-Term Incentive Compensation Plan provides for shares of common stock to be awarded to officers and key employees based on performance targets set by the Compensation Committee of the Board of Directors (the “Committee”). The Company’s shareholders previously approved 700,000 shares to be issued under the plan. As of December 31, 2018, 102,183 shares have been issued.  The Committee selected fully-diluted earnings per share as the performance goal for the three-year performance periods July 1, 2016 – June 30, 2019 (2017-2019) and July 1, 2017 – June 30, 2020 (2018-2020), and July 1, 2018 – June 30, 2021 (2019-2021). The Committee also selected total shareholder return as a performance goal for the executive officers for the three-year performance periods 2017-2019, 2018-2020 and 2019-2021. Stock awards will be issued to participants as soon as practicable following the end of the performance periods subject to verification of results and Committee approval. The compensation cost related to the number of shares to be granted under each performance period is fixed on the grant date, which is the date the performance period begins.



During the quarters and six months ended December 31, 2018 and 2017, the Company recorded no plan expense. If the target performance goals for 2017-2019, 2018-2020 and 2019-2021 plans would be achieved, the total amount of compensation cost recognized over the requisite performance periods would be $0.9 million,  $0.6 million and $0.4 million, respectively.



(2)Stock Plans



Omnibus Stock Plan



The Omnibus Stock Plan is for key employees, officers and directors and provides for the granting of incentive and nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights and performance units. The Company’s shareholders previously approved 700,000 shares to be issued under the plan.



Under the Omnibus Stock Plan, options are granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years.  It is the Company’s policy to issue new shares upon exercise of stock options. The Company accepts shares of the Company’s common stock as payment for the exercise price of options. Shares received as payment are retired upon receipt. During the quarter ended December 31, 2018, the Company issued options for 30,210 common shares and recorded expense of $0.1 million related to stock option grants. The Company did not issue options or record expense for the quarter ended December 31, 2017.



During the six months ended December 31, 2018 and 2017, the Company issued options for 66,305 and 21,439 common shares and recorded expense of $0.4 million and $0.2 million related to stock option grants, respectively.



Under the Omnibus Stock Plan, the Company issued 3,675 and 1,701 shares to non-executive directors as compensation and recorded expense of $0.1 million during the quarters ended December 31, 2018 and 2017, respectively. The Company issued 6,265 and 3,564 shares to non-executive directors as compensation and recorded expense of $0.2 million during the six months ended December 31, 2018 and 2017, respectively.



During the three and six months ended December 31, 2018, the Company recorded $0.1 million and $0.3 million compensation expense for grants of an aggregate 39,666 restricted stock units under the plan to four executive officers as per their notification of award letters dated July 1, 2018. In addition, the Company awarded 30,000 restricted stock units and 3,186 restricted stock shares to its Chief Executive Officer per notification of award letters dated December 28, 2018. During the three and six months ended December 31, 2017, the Company recorded $0.1 million and $0.2 million compensation expense for grants of an aggregate 6,280 restricted stock units under the plan to two executive officers as per their notification of award letters dated July 1, 2017.



At December 31, 2018, 406,152 shares were available for future grants under the plan.  



2006 and 2009 Stock Option Plans



The 2006 and 2009 Stock Option Plans are for key employees, officers and directors and provide for granting incentive and nonqualified stock options. Under the plans, options were granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. All options were exercisable when granted. No additional options can be granted under the 2006 and 2009 Stock Option Plans.



(3) Outside a Plan



During the quarter ended December 31, 2018, the Company awarded its Chief Executive Officer 55,000 options outside any Company stock plan. The Company recorded no compensation expense related to this grant during the quarter and six months ended December 31, 2018.



(4)Summary



A summary of the status of the Company’s stock plans as of December 31, 2018, June 30, 2018 and 2017  and the changes during the periods then ended is presented below:





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

 

 

 

Weighted

 

 

Aggregate



 

Shares

 

 

Average

 

 

Intrinsic Value



 

(in thousands)

 

 

Exercise Price

 

 

(in thousands)

Outstanding and exercisable at June 30, 2017

 

187 

 

$

27.21

 

$

5,039

Granted

 

21 

 

 

45.21

 

 

 

Exercised

 

(21)

 

 

18.89

 

 

 

Canceled

 

(21)

 

 

26.77

 

 

 

Outstanding and exercisable at June 30, 2018

 

166 

 

$

30.65

 

$

1,841

Granted

 

66 

 

 

27.87

 

 

 

Exercised

 

(4)

 

 

13.81

 

 

 

Canceled

 

(7)

 

 

36.58

 

 

 

Outstanding and exercisable at December 31, 2018

 

221 

 

$

29.90

 

$

246



The following table summarizes information for options outstanding and exercisable at December 31, 2018:





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

 

Options

 

 



 

 

Outstanding and

 

Weighted Average



Range of

 

Exercisable

 

Remaining

 

 

Exercise



Prices

 

(in thousands)

 

Life (Years)

 

 

Price

$

8.55 - 13.90

 

14 

 

2.2 

 

$

11.91 



17.23 - 19.77

 

26 

 

3.3 

 

 

18.88 



20.50 - 27.57

 

66 

 

7.0 

 

 

23.91 



31.06 - 32.80

 

64 

 

8.0 

 

 

32.30 



43.09 - 47.45

 

51 

 

7.7 

 

 

45.37 

$

8.55 - 47.45

 

221 

 

6.7 

 

$

29.90